7 assets in Lymphedema

Therapeutic assets addressing Lymphedema, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Tacrolimus Lymphedema	Odense University Hospital	P2/3	B (61)
Pentoxifylline Lymphedema	M.D. Anderson Cancer Center	P2	B (57)
Indocyanine Green Lymphedema	City of Hope Medical Center	P2	CCC (53)
Pirfenidone Lymphedema	M.D. Anderson Cancer Center	P2	CCC (53)
Pravastatin Lymphedema	M.D. Anderson Cancer Center	P2	CCC (53)
(Rs)-Ketoprofen Lymphedema	M.D. Anderson Cancer Center	P2	CCC (53)
Tocopherol Lymphedema	M.D. Anderson Cancer Center	P2	CCC (53)